Nasser Selim M, Cibas Edmund S, Crum Christopher P, Faquin William C
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Cancer. 2003 Oct 25;99(5):272-6. doi: 10.1002/cncr.11721.
Cervical cytologic specimens that show a low-grade squamous intraepithelial lesion (LSIL) occasionally contain a few cells that are suspicious for, but not diagnostic of, a high-grade squamous intraepithelial lesion (HSIL). In such cases, a diagnosis of LSIL cannot exclude HSIL is rendered. The objective of the current study was to assess the positive predictive value (PPV) for HSIL in follow-up cervical biopsies for these cases.
One hundred forty-four women with a Papanicolaou (Pap) diagnosis of LSIL cannot exclude HSIL and their follow-up cervical biopsies were reviewed. Results were compared with a control group of 155 women with a Pap diagnosis of LSIL. A subset of biopsies was tested and typed for human papillomavirus (HPV) DNA by polymerase chain reaction amplification using consensus primers followed by restriction fragment length polymorphism analysis. HPVs were scored as low-risk or high-risk types.
Women with LSIL cannot exclude HSIL had a higher incidence of HSIL (PPV = 29%) on follow-up cervical biopsy than the control group (PPV = 15%, P < 0.01). In addition, SIL, indeterminate grade was diagnosed in 10% of cervical biopsies in the study group as compared with 4% in controls. Review of Pap smears from the study group showed that there were 3 types of cells suspicious for a high-grade lesion: atypical squamous metaplastic cells (62%), atypical keratinized cells (20%), and dysplastic cells of borderline nuclear-to-cytoplasm ratio (18%). HPV analysis confirmed the presence of high-risk HPV types in the study cases with high-grade cervical biopsies.
Women with a Pap diagnosis of LSIL cannot exclude HSIL appear to be more likely to harbor a high-grade lesion than those diagnosed with LSIL alone. Its use appears warranted. Women with this diagnosis merit appropriate clinical follow-up to exclude HSIL.
显示低度鳞状上皮内病变(LSIL)的宫颈细胞学标本偶尔会包含一些细胞,这些细胞可疑为高级别鳞状上皮内病变(HSIL),但不能确诊。在这种情况下,会做出不能排除HSIL的LSIL诊断。本研究的目的是评估这些病例在后续宫颈活检中HSIL的阳性预测值(PPV)。
回顾了144例巴氏(Pap)诊断为不能排除HSIL的LSIL的女性及其后续宫颈活检情况。将结果与155例巴氏诊断为LSIL的女性对照组进行比较。使用通用引物通过聚合酶链反应扩增对一部分活检组织进行人乳头瘤病毒(HPV)DNA检测和分型,随后进行限制性片段长度多态性分析。HPV被分为低风险或高风险类型。
不能排除HSIL的LSIL女性在后续宫颈活检中HSIL的发生率(PPV = 29%)高于对照组(PPV = 15%,P < 0.01)。此外,研究组10%的宫颈活检诊断为不确定级别的SIL,而对照组为4%。对研究组巴氏涂片的回顾显示,有3种类型的细胞可疑为高级别病变:非典型鳞状化生细胞(62%)、非典型角化细胞(20%)和核质比临界的发育异常细胞(18%)。HPV分析证实高级别宫颈活检的研究病例中存在高风险HPV类型。
巴氏诊断为不能排除HSIL的LSIL女性似乎比仅诊断为LSIL的女性更有可能患有高级别病变。其使用似乎是合理的。有此诊断的女性应进行适当的临床随访以排除HSIL。